Year: 2025

Simplifying Compliance Certifications in Noida – Partner with ACPL In today’s rapidly evolving regulatory environment, compliance is not just a necessity – it’s the backbone of business credibility. At Accredited Consultants Pvt. Ltd. (ACPL), based in Noida, we take pride in being a one-stop solution for all your compliance certification…

New MoCRA Adverse Event Reporting Requirements: Impact on the Cosmetic Industry Product safety and consumer protection are the cornerstones of the cosmetics industry, now reinforced by regulatory milestones like the Modernization of Cosmetics Regulation Act (MoCRA) of 2022 and its 2023 amendment. These legislative advancements underscore the rising importance of…

India may soon start training drug regulators from select foreign countries on drug regulatory practices and pharmacovigilance, officials familiar with the matter said on Wednesday. The project could involve drug regulators and inspectors from African, Southeast Asian, and South Asian Association for Regional Cooperation (SAARC) countries, focusing on drug regulatory…

Regarding manufacturers requesting an extension to adopt the updated Schedule M, the Central Drugs Standard Control Organization (CDSCO) has developed an online application process via the Online National Drugs Licensing System (ONDLS) (www.statedrugs.gov.in). Manufacturers seeking an extension to adopt the updated Schedule M can apply online through the Online National…

Pharmacovigilance in African Countries: Progress and Initiatives African nations have made significant strides in strengthening pharmacovigilance systems to ensure medicine safety and protect public health. Through collaborative efforts and regulatory harmonization, these countries are developing robust mechanisms for monitoring adverse drug reactions (ADRs) and ensuring safer healthcare outcomes. 1. DNDi…